Falcigo Injection is an antimalarial medicine used for the treatment of severe malaria, including cerebral malaria caused by Plasmodium falciparum, in adults and children. It is administered when oral antimalarial medicines cannot be used or are not appropriate.
It contains artesunate. Artesunate generates reactive free radicals within the malaria parasite, damaging essential parasite proteins and leading to rapid parasite clearance. This medicine is administered intravenously or intramuscularly by a healthcare professional according to established treatment guidelines.
Adequate fluid intake, nutritional support, and complete rest under close clinical monitoring are important during recovery from severe malaria.
Inform your healthcare provider if you have pre-existing liver, kidney, or heart disorders. Follow-up blood tests may be required after treatment to monitor for delayed haemolysis. Pregnant women with severe malaria should receive artesunate if recommended by their doctor.






























































